EP2395968
Lyfjasamsetning sem inniheldur glúkópýranósýl-dífenýlmetan-afleiður, lyfjaskammtaform þar af, aðferð til framleiðslu á þeim og notkun á þeim fyrir bætta sykurstjórn í sjúklingi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.2.2010EP published:
17.1.2024EP application number:
10703652.7
EP translation filed:
25.3.2024Grant published:
15.5.2024EPO information:
European Patent Register
Max expiry date:
10.2.2030Expiry date:
10.2.2027Next due date:
28.2.2027
Title in English:
PHARMACEUTICAL COMPOSITION COMPRISING GLUCOPYRANOSYL DIPHENYLMETHANE DERIVATIVES, PHARMACEUTICAL DOSAGE FORM THEREOF, PROCESS FOR THEIR PREPARATION AND USES THEREOF FOR IMPROVED GLYCEMIC CONTROL IN ALanguage of the patent:
English
Timeline
Today
11.2.2010EP application
17.1.2024EP Publication
25.3.2024Translation submitted
15.5.2024Registration published
10.2.2027Expires
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Inventor
Name:
EISENREICH, WolframAddress:
55216 Ingelheim Am Rhein, DE
Name:
LADYZHYNSKY, Nadia S.Address:
Ridgefield, CT 06877, US
Name:
LI, DanpingAddress:
Ridgefield, CT 06877, US
Name:
SCHULTZ, LeonAddress:
Ridgefield, CT 06877, US
Name:
WANG, ZerenAddress:
Ridgefield, CT 06877, US
Name:
MACHA, SreerajAddress:
Ridgefield, CT 06877, US
Name:
BARTA, AlbertAddress:
55216 Ingelheim Am Rhein, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
152317 PDate:
13.2.2009Country:
US
Number:
254033 PDate:
22.10.2009Country:
US
Classification
Categories:
A61K 9/00, A61K 9/16, A61K 9/20, A61K 31/431, A61K 31/7004, A61P 3/04, A61P 3/06, A61P 3/10, A61K 9/48, A61P 3/00, A61P 3/08
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 20.2.2024
Expires: 10.2.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 16
Paid: 11.2.2025
Expires: 10.2.2026
Payer: G.H. Sigurgeirsson ehf.
Number: 17
Paid: 16.2.2026
Expires: 10.2.2027
Payer: G.H. Sigurgeirsson ehf.